M-302

N/A

Report date: 2025/07/01 11:36:10

Base Information

Drug NameM-302
Drug Alias NameM-302
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLymphoma, T-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesFutureGen Biopharm (Beijing) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFutureGen Biopharm (Beijing) Co Ltd
Active IndicationsN/A
Inactive IndicationsLymphoma, T-Cell

Other Information

ATC CodeN/A
Related LinksN/A